The guidelines outlined the roles and responsibilities of the CDSCO’s Zonal, Sub-zonal, and Port offices and were released on September 12, marking the first update since 2011
Read MoreUnder the agreement, Biocon Biologics is licensed to launch Bmab 1200 in the United States, scheduled for February 2025, subject to approval by the U.S. FDA
Read MoreFor India and Indian companies to fulfil their enormous promise, a greater outlay towards research is paramount
Read MoreThe shortest budget, very high on rhetoric, throws up serious questions which the discerning public demands answers, writes JK Dadoo
Read MoreThis additional patent solidifies and augments the original invention, unveiling unique features with the potential to enhance precision and productivity across various applications
Read MoreThe company received final approval for manufacturing and marketing Gabapentin tablets in 300 mg and 600 mg strengths, making it the first to receive such approval
Read MoreThe approvals include five final approvals for medications such as Selexipag Tablets (multiple strengths), Dapsone gel (7.5 per cent), Fluorouracil Injection USP 5g/100mL (50 mg/mL), Carmustine for Injection USP 100 mg/vial, and Acyclovir Cream (5 per cent)
Read MoreThis approval positions Lupin to market a generic equivalent to the reference listed drug (RLD) Alrex Ophthalmic Suspension, 0.2 per cent, produced by Bausch & Lomb
Read More